Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 11 de 11
Journal of the Pakistan Medical Association ; 72(12):2482-2485, 2022.
Article in English | EMBASE | ID: covidwho-2164793
Ieee Sensors Letters ; 6(2):4, 2022.
Article in English | Web of Science | ID: covidwho-1746045
European Heart Journal ; 43(SUPPL 1):i227, 2022.
Article in English | EMBASE | ID: covidwho-1722402
European Journal of Nuclear Medicine and Molecular Imaging ; 48(SUPPL 1):S150-S151, 2021.
Article in English | Web of Science | ID: covidwho-1609750
IEEE Sensors Letters ; 2021.
Article in English | Scopus | ID: covidwho-1575426
Proceedings of 2020 6th Ieee International Women in Engineering ; : 247-250, 2020.
Article in English | Web of Science | ID: covidwho-1349919
American Journal of Gastroenterology ; 115:S685-S686, 2020.
Article in English | Web of Science | ID: covidwho-1070082
Mymensingh Med J ; 29(2): 488-494, 2020 Apr.
Article in English | MEDLINE | ID: covidwho-832345


Since the first recorded case of SARS-CoV-2 in Bangladesh on 8th March 2020, COVID-19 has spread widely through different regions of the country, resulting in a necessity to re-evaluate the delivery of cardiovascular services, particularly procedures pertaining to interventional cardiology in resource-limited settings. Given its robust capacity for human-to-human transmission and potential of being a nosocomial source of infection, the disease has specific implications on healthcare systems and health care professionals faced with performing essential cardiac procedures in patients with a suspected or confirmed diagnosis of COVID-19. The limited resources in terms of cardiac catheterization laboratories that can be designated to treat only COVID positive patients are further compounded by the additional challenges of unavailability of widespread rapid testing on-site at tertiary cardiac hospitals in Bangladesh. This document prepared for our nation by the Bangladesh Society of Cardiovascular Interventions (BSCI) is intended to serve as a clinical practice guideline for cardiovascular health care professionals, with a focus on modifying standard practice of care during the COVID-19 pandemic, in order to ensure continuation of adequate and timely treatment of cardiovascular emergencies avoiding hospital-based transmission of SARS-COV-2 among healthcare professionals and the patients. This is an evolving document based on currently available global data and is tailored to healthcare systems in Bangladesh with particular focus on, but not limited to, invasive cardiology facilities (cardiac catheterization, electrophysiology & pacing labs). This guideline is limited to the provision of cardiovascular care, and it is expected that specific targeted pharmaco-therapeutics against SARS-CoV-2 be prescribed as stipulated by the National Guidelines on Clinical Management of Corona virus Disease 2019 (COVID-19) published by the Director General of Health Services, Ministry of Health and Family Welfare of Bangladesh.

Cardiovascular Diseases , Cardiovascular Surgical Procedures , Coronavirus Infections , Pandemics , Pneumonia, Viral , Bangladesh , Betacoronavirus , COVID-19 , Cardiovascular Diseases/therapy , Coronavirus Infections/complications , Coronavirus Infections/epidemiology , Humans , Pneumonia, Viral/complications , Pneumonia, Viral/epidemiology , SARS-CoV-2